146 related articles for article (PubMed ID: 29274027)
1. Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study.
Mizia-Stec K; Elżbieciak M; Wybraniec MT; Różewicz M; Bodys A; Braksator W; Gąsior Z; Gościniak P; Hryniewiecki T; Kasprzak J; Wojtarowicz A; Zdziarska B; Płońska-Gościniak E
Med Oncol; 2017 Dec; 35(1):14. PubMed ID: 29274027
[TBL] [Abstract][Full Text] [Related]
2. [Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma].
Dorokhina EI; Magomedova AU; Shevelev AA; Kulikov SM; Gitis MK; Vedernikov AV; Vorobyev AI; Kravchenko SK
Ter Arkh; 2015; 87(7):51-57. PubMed ID: 26390725
[TBL] [Abstract][Full Text] [Related]
3. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
5. 3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin's lymphoma.
Mihalcea D; Florescu M; Bruja R; Patrascu N; Vladareanu AM; Vinereanu D
Sci Rep; 2020 Oct; 10(1):18473. PubMed ID: 33116212
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial.
Xue K; Gu JJ; Zhang Q; Liu X; Wang J; Li XQ; Luo J; Hernandez-Ilizaliturri FJ; Fernandez SF; Czuczman MS; Cao J; Hong X; Guo Y
Oncotarget; 2016 May; 7(22):32519-31. PubMed ID: 27081036
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
Szmit S; Jurczak W; Zaucha JM; Drozd-Sokołowska J; Spychałowicz W; Joks M; Długosz-Danecka M; Torbicki A
J Am Soc Hypertens; 2014 Nov; 8(11):791-9. PubMed ID: 25455004
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
Bergamini C; Torelli F; Ghiselli L; Rossi A; Trevisani L; Vinco G; Truong S; Benfari G; LA Russa F; Golia G; Molino A; Vassanelli C
Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
[TBL] [Abstract][Full Text] [Related]
9. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
Wang W; Kang Y; Shu XH; Shen XD; He B
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
[No Abstract] [Full Text] [Related]
10. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E
J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030
[TBL] [Abstract][Full Text] [Related]
11. Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen.
Wang B; Yu Y; Zhang Y; Hao X; Zhao H; Yang S; Sun Q; Wang Y
Echocardiography; 2020 Mar; 37(3):421-428. PubMed ID: 32112477
[TBL] [Abstract][Full Text] [Related]
12. Early anthracycline-induced cardiotoxicity monitored by echocardiographic Doppler parameters combined with serum hs-cTnT.
Zhang CJ; Pei XL; Song FY; Guo Y; Zhang QL; Shu XH; Hsi DH; Cheng LL
Echocardiography; 2017 Nov; 34(11):1593-1600. PubMed ID: 28942608
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction.
Di Lisi D; Bonura F; Macaione F; Peritore A; Meschisi M; Cuttitta F; Novo G; D'Alessandro N; Novo S
Anticancer Drugs; 2011 Jun; 22(5):468-72. PubMed ID: 21301318
[TBL] [Abstract][Full Text] [Related]
15. Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
Olivieri J; Perna GP; Bocci C; Montevecchi C; Olivieri A; Leoni P; Gini G
Oncologist; 2017 Apr; 22(4):422-431. PubMed ID: 28275118
[TBL] [Abstract][Full Text] [Related]
16. Tissue Doppler echocardiography detects subclinical left ventricular dysfunction in patients undergoing chemotherapy for colon cancer: insights from ONCOECHO multicentre study.
Płońska-Gościniak E; Różewicz M; Kasprzak J; Wojtarowicz A; Mizia-Stec K; Hryniewiecki T; Pysz P; Kułach A; Bodys A; Sulżyc V; Braksator W; Szyszka A; Zaborska B; Gościńska-Szmagała A; Siński M; Kosior D; Szmit S; Kowalik I; Gąsior Z
Kardiol Pol; 2017; 75(2):150-156. PubMed ID: 27878803
[TBL] [Abstract][Full Text] [Related]
17. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group.
Krupicka J; Marková J; Pohlreich D; Kozák T; Línková H; Diehl V;
Leuk Lymphoma; 2002 Dec; 43(12):2325-9. PubMed ID: 12613519
[TBL] [Abstract][Full Text] [Related]
19. Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.
Dong Q; Ou W; Wang M; Jiang T; Weng Y; Zhou X; Tang X
BMC Cancer; 2022 Sep; 22(1):988. PubMed ID: 36115970
[TBL] [Abstract][Full Text] [Related]
20. [Damage of left ventricular function after treatment with doxorubicin in patients with malignant lymphomas].
Elbl L; Chaloupka V; Vásová I; Nehyba S; Vorlícek J; Navrátil M; Kiss I; Cíhalová M
Vnitr Lek; 2000 Nov; 46(11):768-75. PubMed ID: 15637892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
